PERCEPTIVE ADVISORS LLC
CIK 1224962 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.14B
Companies
28
Total Filings
74
Lifetime Open-Market Net
$647.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLDB | Director | 73,107 | $7.14 | $522.0K | $80.60M | 7 | 2026-06-11 |
| MGTX | Director | 11,281,103 | $9.59 | $108.19M | $178.27M | 8 | 2025-06-16 |
| ADGM | Director | 9,876,586 | $0.74 | $7.36M | $0 | 1 | 2025-02-14 |
| NAUT | Director | — | $2.24 | — | $0 | 3 | 2024-06-17 |
| VRCA | 10%+ Owner | 6,722,914 | $5.73 | $38.52M | $54.77M | 2 | 2023-12-26 |
| SLNO | 10%+ Owner | 2,270,473 | $53.01 | $120.36M | $45.34M | 1 | 2023-09-28 |
| LianBio (LIAN) Delisted | Director | — | $0.32 | — | $0 | 2 | 2023-06-23 |
| LYRA | Director | 1,288,446 | $0.70 | $902.0K | $36.00M | 2 | 2023-06-02 |
| CHEMBIO DIAGNOSTICS, INC. (CEMI) Delisted | 10%+ Owner | 4,863,334 | $0.46 | $2.21M | $451.2K | 2 | 2023-04-20 |
| ALDX | 10%+ Owner | 10,801,985 | $1.76 | $19.01M | $11.27M | 2 | 2022-08-04 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | 4,843,095 | $18.07 | $87.51M | $15.00M | 1 | 2021-07-09 |
| VBI Vaccines Inc/BC (VBIV) Delisted | 10%+ Owner | 0 | $0.07 | $0 | $35.56M | 3 | 2021-06-30 |
| Landos Biopharma, Inc. (LABP) Delisted | Director | 2,941,769 | $22.93 | $67.45M | $100.00M | 1 | 2021-02-08 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 1 | 2021-02-03 |
| MOTS | 10%+ Owner | 3,210,542 | $0.00 | $321 | $10.79M | 3 | 2021-01-22 |
| CRNX | 10%+ Owner | 3,659,381 | $34.47 | $126.14M | $45.00M | 1 | 2020-04-20 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | 10%+ Owner | 1,960,139 | $44.15 | $86.54M | $16.12M | 1 | 2020-02-04 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | 10%+ Owner | 20,724,424 | $14.49 | $300.30M | $0 | 1 | 2019-02-19 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | 10%+ Owner | 4,313,611 | $6.22 | $26.83M | $79.13M | 2 | 2018-03-26 |
| Corium International, Inc. (CORI) Delisted | 10%+ Owner | 5,847,133 | — | — | $6.96M | 1 | 2017-07-05 |
| TALPHERA, INC. (ACRX) Delisted | 10%+ Owner | 6,467,560 | $0.86 | $5.56M | $11.38M | 2 | 2013-11-12 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | 10%+ Owner | 2,823,426 | — | — | -$153.82M | 4 | 2013-09-09 |
| REPROS THERAPEUTICS INC. (RPRX.Z) Delisted | 10%+ Owner | — | — | — | $0 | 4 | 2013-02-13 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2011-11-09 |
| REPROS THERAPEUTICS INC. (RPRXZ) Delisted | 10%+ Owner | 1,982,460 | — | — | $12.38M | 3 | 2011-08-24 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | 10%+ Owner | 6,476,446 | — | — | $279.5K | 7 | 2009-03-31 |
| IDEV | 10%+ Owner | 7,891,067 | $90.39 | $713.27M | $5.16M | 2 | 2009-03-09 |
| XTLB | 10%+ Owner | 3,069,180 | $2.13 | $6.54M | $57.30M | 5 | 2008-06-11 |
Recent Filings · Page 5 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-26 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +2,100,000 | $61.95M | EDGAR |
| 2018-02-21 | MOTS | Mixed | +3,769,158 | $15.00M | EDGAR |
| 2018-02-15 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Buy (P) | +525,000 | $17.18M | EDGAR |
| 2017-09-21 | ALDX | Buy (P) | +600,000 | $4.35M | EDGAR |
| 2017-07-05 | Corium International, Inc. (CORI) Delisted | Buy (P) | +903,012 | $6.96M | EDGAR |
| 2017-03-09 | — | Buy (P) | +10,151,865 | $30.96M | |
| 2013-11-12 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +600,000 | $3.90M | EDGAR |
| 2013-11-04 | TALPHERA, INC. (ACRX) Delisted | Buy (P) | +1,081,980 | $7.47M | EDGAR |
| 2013-09-09 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | −1,650,000 | -$185.70M | EDGAR |
| 2013-02-13 | REPROS THERAPEUTICS INC. (RPRX.Z) Delisted | Mixed | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.